Loading…
Lipoxygenase in Condition of Experimental Hypertriacylglycerolaemia
Animal lipoxygenases (EC 1.13.11.12, LOX) convert arachidonic acid to biological active compounds known as eicosanoids. Proinflammatory eicosanoids - leukotrienes are involved in progression of atherosclerosis. Our attention was focused on a connection between activity of LOX and primary hypertriacy...
Saved in:
Published in: | Acta Facultatis Pharmaceuticae Universitatis Comenianae 2013-06, Vol.LX (1), p.21-25 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Animal lipoxygenases (EC 1.13.11.12, LOX) convert arachidonic acid to biological active compounds known as eicosanoids. Proinflammatory
eicosanoids - leukotrienes are involved in progression of atherosclerosis. Our attention was focused on a connection
between activity of LOX and primary hypertriacylglycerolaemia, untreated or treated with fenofibrate. Our results show that
LOX activity in the cytoplasm derived from liver of hypertriacylglycerolaemic rats is significantly increased (pH 7,2; relative to the
control group), which may be one reason for more rapid atherosclerosis progression in lipid metabolism disorders. The highest
LOX activity in microsomes was showed in groups of rats treated with fenofibrate. It appears that fibrates indirectly promote association
of LOXs to membranes. In fat fraction no significant effect of hypertriacylglycerolaemia on the activity of lipoxygenase
was found. Using gel electrophoresis significantly different spectrum of proteins was discovered in the control samples and
samples of hypertriacylglycerolaemic rats. It appears that in condition of lipid metabolism imbalance formation of proteins with
low molecular weight (and possibly also expression of LOX) is elevated. |
---|---|
ISSN: | 0301-2298 1338-6786 2453-6725 |
DOI: | 10.2478/afpuc-2013-0011 |